Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Therapeutic Drug Monitoring|June 20, 2014
Gentamicin and renal function: lessons from 15 years' experience of a pharmacokinetic service for extended interval dosing of gentamicinSabine M Plajer, Paul K L Chin, Jane W A Vella-Brincat, et al.British Journal of Clinical Pharmacology|January 17, 2007
Protein binding of cefazolin is saturable in vivo both between and within patientsJane W A Vella-Brincat, Evan J Begg, Carl M J Kirkpatrick, et al.The Journal of Antimicrobial Chemotherapy|March 21, 2009
Eight years' experience of an extended-interval dosing protocol for gentamicin in neonatesEvan J Begg, Jane W A Vella-Brincat, Barbara Robertshawe, et al.Neonatology|April 2, 2011
Are gentamicin and/or vancomycin associated with ototoxicity in the neonate? A retrospective auditJane W A Vella-Brincat, Evan J Begg, Barbara J Robertshawe, et al.The Journal of Antimicrobial Chemotherapy|March 12, 2004
Stability of benzylpenicillin during continuous home intravenous therapyJane W A Vella-Brincat, Evan J Begg, Kate Gallagher, et al.Journal of Pain and Symptom Management|January 3, 2012
The pharmacokinetics and pharmacogenetics of the antiemetic cyclizine in palliative care patientsJane W A Vella-Brincat, Evan J Begg, Berit P Jensen, et al.Pageof 1